Bloomberg

Novavax Seeks U.K. Approval; Merck Pill Access: Virus Update

Novavax Inc. filed for authorization of its vaccine in the U.K., and Merck & Co. reached a licensing agreement aimed at widening access to its promising Covid pill. Health advocates hope the pact will spur other pharmaceutical companies to act.

Continue

About the author

Angela

Leave a Comment